Kinsey M. Johannemann, PharmD, BCPS

Articles by Kinsey M. Johannemann, PharmD, BCPS

Intensive care unit (ICU) -- Image credit: sudok1 | stock.adobe.com

The Impact of Pharmacist-Managed Insulin Therapy in the Intensive Care Unit

BySydney K. Davis, PharmD,Michael A. Maccia, PharmD, BCCCP,Kinsey M. Johannemann, PharmD, BCPS,Eden E. Brewington, PharmD, BCCCP,Daniel C. Smith, MD

July 21st 2025

Critically ill patients treated with a pharmacist-managed insulin protocol achieved higher rates of glucose control than those treated with conventional methods.

Kinsey M. Johannemann, PharmD, BCPS

Articles by Kinsey M. Johannemann, PharmD, BCPS

The Impact of Pharmacist-Managed Insulin Therapy in the Intensive Care Unit

Latest Updated Articles

Trending on Pharmacy Times - Pharmacy Practice News and Expert Insights

FDA Approves Imlunestrant Tablets for ER+, HER2–, ESR1-Mutated Advanced or Metastatic Breast Cancer

IMWG Consensus Risk Criteria Predicts Survival in Daratumumab Quadruplet Therapy

Linvoseltamab Monotherapy Elicits Promising ORR, MRD-Negativity in NDMM

How Pharmacists Support CDK4/6 Inhibitor Management and Patient Care

Post-Marketing Surveillance Study Affirms Safety of Pneumococcal Vaccines